HUMACYTE, INC. (HUMA)
Humacytes Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
Humacytes Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
Chaince Digital Announces Launch of USDC Yield Vault on Morpho Curated by AlphaPing
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Byrna Technologies Realigns Sales and Marketing Function to Strengthen Brand Messaging and Accelerate Retail Expansion; Appoints HLK as Agency of Record
Oxford Lane Capital Corp. Provides May 2026 Net Asset Value Update
Hillshire Reserve™ Brand Redefines Lunchmeat for More Versatile, Elevated Everyday Eating
Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
Swarmer and Molfar Partner to Integrate Verified Intelligence Data for Autonomous Systems
Meat is the Make-or-Break Factor in Sandwich Satisfaction, New Survey Finds